[JAMA Oncol] reverse: Anthracycline not Affect Cognitive Function in Breast Cancer Survivors
12
May
![[JAMA Oncol] reverse: Anthracycline not Affect Cognitive Function in Breast Cancer Survivors](https://www.medicinetechnews.com/wp-content/uploads/2016/05/330751-14112113012412.jpg)
JAMA Oncol Following a retrospective study published in February, suggesting that anthracycline-based chemotherapy in breast cancer survivors may cause cognitive impairment, recently published another study. This study is an early study of patients were followed up for 7 years and … Read More »